More than 66,000 Americans will be diagnosed with pancreatic cancer this year. Learn more about the disease and how PanCAN can help.

Pancreatic cancer is a disease in which malignant cells originate in the pancreatic tissue. Cancer of the exocrine component of the pancreas (adenocarcinomas) represents the majority of pancreatic ...

While pancreatic cancer remains one of the toughest cancers to treat and is predicted to become the second-leading cause of cancer-related death in the U.S. before 2030, research and treatment ...

In pancreatic cancer patients, a key indicator could be "pale," clay-like stool and dark-colored urine. A habitat for bacteria could be more detrimental than a toilet seat. Additional symptoms of ...

Jan. 10, 2025 — A study shares new insights into how two of the most common types of chimeric antigen receptor (CAR) T cells kill cancer. Investigators examined how molecular dynamics at the ...

providing insights into the ultrastructural changes associated with pancreatic cancer progression and treatment responses. This review traces the current and technological advances in EM, particularly ...

Macrophages can be repolarised via inhibition of the phosphoinositide 3-kinase-gamma (PI3Kγ) pathway, but this has little impact on the growth of pancreatic cancer. Macrophage efferocytosis induces a ...

Use precise geolocation data and actively scan device characteristics for identification. This is done to store and access ...

“Non-melanoma skin cancers usually don’t affect the price of life insurance at all, while a pancreatic cancer diagnosis might make it nearly impossible to get coverage. A malignant cancer ...

It is now well established that PSC are responsible for producing the stromal reaction (fibrosis) of two major diseases of the pancreas—chronic pancreatitis and pancreatic cancer. Despite ...